Funding rounds
2 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Jan 2014 | $23 M | No. 2 | $10 to $50 million | equity | SEC | |
| Dec 2012 | $30 M | No. 1 | $10 to $50 million | equity | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Nuron Biotech, Inc. chose not to state its revenue in its newest notice of a funding round (Feb 2014).
SEC Form D · Feb 2014
The industry group it chose in its notices: Biotechnology.
SEC Form D · Feb 2014
That is all the official record says: Nuron Biotech, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
No investor of Nuron Biotech, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 7 investors.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Andrew L. Romberger, Esq. | Executive officer | Feb 2014 |
| Warren D. Cooper | Executive officer | Feb 2014 |
| Wendy D. DiCocco, CPA | Executive officer | Feb 2014 |
| Andrew Romberger, Esq. | Executive officer | Jan 2013 |
| David C. Zeng, Ph.D. | Executive officer | Jan 2013 |
| Mark C. Ambrose | Executive officer | Jan 2013 |
| Richard Dinovitz | Executive officer | Jan 2013 |
| Shankar Musunuri | Executive officer | Jan 2013 |
| Vijay Tammara, Ph.D. | Executive officer | Jan 2013 |
| Wendy C. DiCicco, CPA | Executive officer | Jan 2013 |
| David D. Zeng, Ph.D. | Director | Feb 2014 |
| Gregory D. Brown | Director | Feb 2014 |
| Matthew Q. Reber | Director | Feb 2014 |
| Mukeshbhai D. Patel | Director | Feb 2014 |
| Shankar Musunuri | Director | Feb 2014 |
| Todd D. Davis | Director | Feb 2014 |
| Vithalbhai D. Dhaduk | Director | Feb 2014 |
| Warren D. Cooper | Director | Feb 2014 |
| David C. Zeng, Ph.D. | Director | Jan 2013 |
| Gregory B. Brown | Director | Jan 2013 |
| Todd C. Davis | Director | Jan 2013 |